Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 332 entries
Sorted by: Best Match Show Resources per page
Co-existence of Crohn's disease, sarcoidosis and malignant lymphomas.

JRSM short reports

Yeboah J, Sharma OP.
PMID: 22393471
JRSM Short Rep. 2012 Feb;3(2):10. doi: 10.1258/shorts.2011.011133. Epub 2012 Feb 14.

No abstract available.

Cite
Yeboah J, Sharma OP. Co-existence of Crohn's disease, sarcoidosis and malignant lymphomas. JRSM Short Rep. 2012;3(2):10doi: 10.1258/shorts.2011.011133.
Yeboah, J., & Sharma, O. P. (2012). Co-existence of Crohn's disease, sarcoidosis and malignant lymphomas. JRSM short reports, 3(2), 10. https://doi.org/10.1258/shorts.2011.011133
Yeboah, John, and Sharma, Om P. "Co-existence of Crohn's disease, sarcoidosis and malignant lymphomas." JRSM short reports vol. 3,2 (2012): 10. doi: https://doi.org/10.1258/shorts.2011.011133
Yeboah J, Sharma OP. Co-existence of Crohn's disease, sarcoidosis and malignant lymphomas. JRSM Short Rep. 2012 Feb;3(2):10. doi: 10.1258/shorts.2011.011133. Epub 2012 Feb 14. PMID: 22393471; PMCID: PMC3291424.
Copy Download .nbib Format: NLM
A PheWAS Model of Autism Spectrum Disorder.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference

Matta J, Dobrino D, Howard S, Yeboah D, Kopel J, El-Manzalawy Y, Obafemi-Ajayi T.
PMID: 34891705
Annu Int Conf IEEE Eng Med Biol Soc. 2021 Nov;2021:2110-2114. doi: 10.1109/EMBC46164.2021.9629533.

Children with Autism Spectrum Disorder (ASD) exhibit a wide diversity in type, number, and severity of social deficits as well as communicative and cognitive difficulties. It is a challenge to categorize the phenotypes of a particular ASD patient with...

Cite
Matta J, Dobrino D, Howard S, et al. A PheWAS Model of Autism Spectrum Disorder. Annu Int Conf IEEE Eng Med Biol Soc. 2021;2021:2110-2114doi: 10.1109/EMBC46164.2021.9629533.
Matta, J., Dobrino, D., Howard, S., Yeboah, D., Kopel, J., El-Manzalawy, Y., & Obafemi-Ajayi, T. (2021). A PheWAS Model of Autism Spectrum Disorder. Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference, 20212110-2114. https://doi.org/10.1109/EMBC46164.2021.9629533
Matta, John, et al. "A PheWAS Model of Autism Spectrum Disorder." Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference vol. 2021 (2021): 2110-2114. doi: https://doi.org/10.1109/EMBC46164.2021.9629533
Matta J, Dobrino D, Howard S, Yeboah D, Kopel J, El-Manzalawy Y, Obafemi-Ajayi T. A PheWAS Model of Autism Spectrum Disorder. Annu Int Conf IEEE Eng Med Biol Soc. 2021 Nov;2021:2110-2114. doi: 10.1109/EMBC46164.2021.9629533. PMID: 34891705.
Copy Download .nbib Format: NLM
Identification of β-strand mediated protein-protein interaction inhibitors using ligand-directed fragment ligation.

Chemical science

Hegedüs Z, Hóbor F, Shoemark DK, Celis S, Lian LY, Trinh CH, Sessions RB, Edwards TA, Wilson AJ.
PMID: 34163995
Chem Sci. 2021 Jan 06;12(6):2286-2293. doi: 10.1039/d0sc05694d.

β-Strand mediated protein-protein interactions (PPIs) represent underexploited targets for chemical probe development despite representing a significant proportion of known and therapeutically relevant PPI targets. β-Strand mimicry is challenging given that both amino acid side-chains and backbone hydrogen-bonds are typically...

Cite
Hegedüs Z, Hóbor F, Shoemark DK, et al. Identification of β-strand mediated protein-protein interaction inhibitors using ligand-directed fragment ligation. Chem Sci. 2021;12(6):2286-2293doi: 10.1039/d0sc05694d.
Hegedüs, Z., Hóbor, F., Shoemark, D. K., Celis, S., Lian, L. Y., Trinh, C. H., Sessions, R. B., Edwards, T. A., & Wilson, A. J. (2021). Identification of β-strand mediated protein-protein interaction inhibitors using ligand-directed fragment ligation. Chemical science, 12(6), 2286-2293. https://doi.org/10.1039/d0sc05694d
Hegedüs, Zsófia, et al. "Identification of β-strand mediated protein-protein interaction inhibitors using ligand-directed fragment ligation." Chemical science vol. 12,6 (2021): 2286-2293. doi: https://doi.org/10.1039/d0sc05694d
Hegedüs Z, Hóbor F, Shoemark DK, Celis S, Lian LY, Trinh CH, Sessions RB, Edwards TA, Wilson AJ. Identification of β-strand mediated protein-protein interaction inhibitors using ligand-directed fragment ligation. Chem Sci. 2021 Jan 06;12(6):2286-2293. doi: 10.1039/d0sc05694d. PMID: 34163995; PMCID: PMC8179271.
Copy Download .nbib Format: NLM
National Study of Excellence in Pediatric Physical Therapy Education: Design, Methods, and Results.

Physical therapy

Moore JG, Birkmeier MC, Lundeen H, Dannemiller L, Anderson DK, Furze JA.
PMID: 34174080
Phys Ther. 2021 Oct 01;101(10). doi: 10.1093/ptj/pzab169.

OBJECTIVE: The purposes of this study were to identify and describe the attributes of excellence and innovation in professional pediatric physical therapy education and develop a conceptual framework identifying dimensions of excellence.METHODS: A multimethod case study design based on...

Cite
Moore JG, Birkmeier MC, Lundeen H, et al. National Study of Excellence in Pediatric Physical Therapy Education: Design, Methods, and Results. Phys Ther. 2021;101(10)doi: 10.1093/ptj/pzab169.
Moore, J. G., Birkmeier, M. C., Lundeen, H., Dannemiller, L., Anderson, D. K., & Furze, J. A. (2021). National Study of Excellence in Pediatric Physical Therapy Education: Design, Methods, and Results. Physical therapy, 101(10), . https://doi.org/10.1093/ptj/pzab169
Moore, James G, et al. "National Study of Excellence in Pediatric Physical Therapy Education: Design, Methods, and Results." Physical therapy vol. 101,10 (2021). doi: https://doi.org/10.1093/ptj/pzab169
Moore JG, Birkmeier MC, Lundeen H, Dannemiller L, Anderson DK, Furze JA. National Study of Excellence in Pediatric Physical Therapy Education: Design, Methods, and Results. Phys Ther. 2021 Oct 01;101(10). doi: 10.1093/ptj/pzab169. PMID: 34174080.
Copy Download .nbib Format: NLM
Bioactivity Signatures of Drugs vs. Environmental Chemicals Revealed by Tox21 High-Throughput Screening Assays.

Frontiers in big data

Ngan DK, Ye L, Wu L, Xia M, Rossoshek A, Simeonov A, Huang R.
PMID: 33693373
Front Big Data. 2019 Dec 13;2:50. doi: 10.3389/fdata.2019.00050. eCollection 2019.

Humans are exposed to tens of thousands of chemicals over the course of a lifetime, yet there remains inadequate data on the potential harmful effects of these substances on human health. Using quantitative high-throughput screening (qHTS), we can test...

Cite
Ngan DK, Ye L, Wu L, et al. Bioactivity Signatures of Drugs vs. Environmental Chemicals Revealed by Tox21 High-Throughput Screening Assays. Front Big Data. 2019;2:50doi: 10.3389/fdata.2019.00050.
Ngan, D. K., Ye, L., Wu, L., Xia, M., Rossoshek, A., Simeonov, A., & Huang, R. (2019). Bioactivity Signatures of Drugs vs. Environmental Chemicals Revealed by Tox21 High-Throughput Screening Assays. Frontiers in big data, 250. https://doi.org/10.3389/fdata.2019.00050
Ngan, Deborah K, et al. "Bioactivity Signatures of Drugs vs. Environmental Chemicals Revealed by Tox21 High-Throughput Screening Assays." Frontiers in big data vol. 2 (2019): 50. doi: https://doi.org/10.3389/fdata.2019.00050
Ngan DK, Ye L, Wu L, Xia M, Rossoshek A, Simeonov A, Huang R. Bioactivity Signatures of Drugs vs. Environmental Chemicals Revealed by Tox21 High-Throughput Screening Assays. Front Big Data. 2019 Dec 13;2:50. doi: 10.3389/fdata.2019.00050. eCollection 2019. PMID: 33693373; PMCID: PMC7931954.
Copy Download .nbib Format: NLM
TNIK Is a Therapeutic Target in Lung Squamous Cell Carcinoma and Regulates FAK Activation through Merlin.

Cancer discovery

Torres-Ayuso P, An E, Nyswaner KM, Bensen RC, Ritt DA, Specht SI, Das S, Andresson T, Cachau RE, Liang RJ, Ries AL, Robinson CM, Difilippantonio S, Gouker B, Bassel L, Karim BO, Miller CJ, Turk BE, Morrison DK, Brognard J.
PMID: 33495197
Cancer Discov. 2021 Jun;11(6):1411-1423. doi: 10.1158/2159-8290.CD-20-0797. Epub 2021 Jan 25.

Lung squamous cell carcinoma (LSCC) is the second most prevalent type of lung cancer. Despite extensive genomic characterization, no targeted therapies are approved for the treatment of LSCC. Distal amplification of the 3q chromosome is the most frequent genomic...

Cite
Torres-Ayuso P, An E, Nyswaner KM, et al. TNIK Is a Therapeutic Target in Lung Squamous Cell Carcinoma and Regulates FAK Activation through Merlin. Cancer Discov. 2021;11(6):1411-1423doi: 10.1158/2159-8290.CD-20-0797.
Torres-Ayuso, P., An, E., Nyswaner, K. M., Bensen, R. C., Ritt, D. A., Specht, S. I., Das, S., Andresson, T., Cachau, R. E., Liang, R. J., Ries, A. L., Robinson, C. M., Difilippantonio, S., Gouker, B., Bassel, L., Karim, B. O., Miller, C. J., Turk, B. E., Morrison, D. K., & Brognard, J. (2021). TNIK Is a Therapeutic Target in Lung Squamous Cell Carcinoma and Regulates FAK Activation through Merlin. Cancer discovery, 11(6), 1411-1423. https://doi.org/10.1158/2159-8290.CD-20-0797
Torres-Ayuso, Pedro, et al. "TNIK Is a Therapeutic Target in Lung Squamous Cell Carcinoma and Regulates FAK Activation through Merlin." Cancer discovery vol. 11,6 (2021): 1411-1423. doi: https://doi.org/10.1158/2159-8290.CD-20-0797
Torres-Ayuso P, An E, Nyswaner KM, Bensen RC, Ritt DA, Specht SI, Das S, Andresson T, Cachau RE, Liang RJ, Ries AL, Robinson CM, Difilippantonio S, Gouker B, Bassel L, Karim BO, Miller CJ, Turk BE, Morrison DK, Brognard J. TNIK Is a Therapeutic Target in Lung Squamous Cell Carcinoma and Regulates FAK Activation through Merlin. Cancer Discov. 2021 Jun;11(6):1411-1423. doi: 10.1158/2159-8290.CD-20-0797. Epub 2021 Jan 25. PMID: 33495197; PMCID: PMC8178189.
Copy Download .nbib Format: NLM
TNIK Is a Therapeutic Target in Lung Squamous Cell Carcinoma and Regulates FAK Activation through Merlin.

Cancer discovery

Torres-Ayuso P, An E, Nyswaner KM, Bensen RC, Ritt DA, Specht SI, Das S, Andresson T, Cachau RE, Liang RJ, Ries AL, Robinson CM, Difilippantonio S, Gouker B, Bassel L, Karim BO, Miller CJ, Turk BE, Morrison DK, Brognard J.
PMID: 33495197
Cancer Discov. 2021 Jun;11(6):1411-1423. doi: 10.1158/2159-8290.CD-20-0797. Epub 2021 Jan 25.

Lung squamous cell carcinoma (LSCC) is the second most prevalent type of lung cancer. Despite extensive genomic characterization, no targeted therapies are approved for the treatment of LSCC. Distal amplification of the 3q chromosome is the most frequent genomic...

Cite
Torres-Ayuso P, An E, Nyswaner KM, et al. TNIK Is a Therapeutic Target in Lung Squamous Cell Carcinoma and Regulates FAK Activation through Merlin. Cancer Discov. 2021;11(6):1411-1423doi: 10.1158/2159-8290.CD-20-0797.
Torres-Ayuso, P., An, E., Nyswaner, K. M., Bensen, R. C., Ritt, D. A., Specht, S. I., Das, S., Andresson, T., Cachau, R. E., Liang, R. J., Ries, A. L., Robinson, C. M., Difilippantonio, S., Gouker, B., Bassel, L., Karim, B. O., Miller, C. J., Turk, B. E., Morrison, D. K., & Brognard, J. (2021). TNIK Is a Therapeutic Target in Lung Squamous Cell Carcinoma and Regulates FAK Activation through Merlin. Cancer discovery, 11(6), 1411-1423. https://doi.org/10.1158/2159-8290.CD-20-0797
Torres-Ayuso, Pedro, et al. "TNIK Is a Therapeutic Target in Lung Squamous Cell Carcinoma and Regulates FAK Activation through Merlin." Cancer discovery vol. 11,6 (2021): 1411-1423. doi: https://doi.org/10.1158/2159-8290.CD-20-0797
Torres-Ayuso P, An E, Nyswaner KM, Bensen RC, Ritt DA, Specht SI, Das S, Andresson T, Cachau RE, Liang RJ, Ries AL, Robinson CM, Difilippantonio S, Gouker B, Bassel L, Karim BO, Miller CJ, Turk BE, Morrison DK, Brognard J. TNIK Is a Therapeutic Target in Lung Squamous Cell Carcinoma and Regulates FAK Activation through Merlin. Cancer Discov. 2021 Jun;11(6):1411-1423. doi: 10.1158/2159-8290.CD-20-0797. Epub 2021 Jan 25. PMID: 33495197; PMCID: PMC8178189.
Copy Download .nbib Format: NLM
Effect of Intensive Blood Pressure Lowering on Incident Atrial Fibrillation: A Systematic Review and Meta-Analysis.

Journal of atrial fibrillation

J Singleton M, Y Chen L, Whalen SP, D Bhave P, H Beaty E, Yeboah J, Z Soliman E.
PMID: 34950321
J Atr Fibrillation. 2020 Dec 31;13(4):2401. doi: 10.4022/jafib.2401. eCollection 2020 Dec.

The effect of intensive versus standard blood pressure (BP) lowering on the risk of atrial fibrillation (AF) is uncertain. Intensive BP lowering is associated with a lower risk of AF among patients with hypertension. We searched PubMed, EMBASE, and...

Cite
J Singleton M, Y Chen L, Whalen SP, et al. Effect of Intensive Blood Pressure Lowering on Incident Atrial Fibrillation: A Systematic Review and Meta-Analysis. J Atr Fibrillation. 2020;13(4):2401doi: 10.4022/jafib.2401.
J Singleton, M., Y Chen, L., Whalen, S. P., D Bhave, P., H Beaty, E., Yeboah, J., & Z Soliman, E. (2020). Effect of Intensive Blood Pressure Lowering on Incident Atrial Fibrillation: A Systematic Review and Meta-Analysis. Journal of atrial fibrillation, 13(4), 2401. https://doi.org/10.4022/jafib.2401
J Singleton, Matthew, et al. "Effect of Intensive Blood Pressure Lowering on Incident Atrial Fibrillation: A Systematic Review and Meta-Analysis." Journal of atrial fibrillation vol. 13,4 (2020): 2401. doi: https://doi.org/10.4022/jafib.2401
J Singleton M, Y Chen L, Whalen SP, D Bhave P, H Beaty E, Yeboah J, Z Soliman E. Effect of Intensive Blood Pressure Lowering on Incident Atrial Fibrillation: A Systematic Review and Meta-Analysis. J Atr Fibrillation. 2020 Dec 31;13(4):2401. doi: 10.4022/jafib.2401. eCollection 2020 Dec. PMID: 34950321; PMCID: PMC8691291.
Copy Download .nbib Format: NLM
Interventional Stroke Management in a Patient With COVID-19.

Neurology. Clinical practice

Yeboah K, Edgell R, Conway J, Alshekhlee A.
PMID: 33842093
Neurol Clin Pract. 2021 Apr;11(2):e199-e201. doi: 10.1212/CPJ.0000000000000884.

No abstract available.

Cite
Yeboah K, Edgell R, Conway J, et al. Interventional Stroke Management in a Patient With COVID-19. Neurol Clin Pract. 2021;11(2):e199-e201doi: 10.1212/CPJ.0000000000000884.
Yeboah, K., Edgell, R., Conway, J., & Alshekhlee, A. (2021). Interventional Stroke Management in a Patient With COVID-19. Neurology. Clinical practice, 11(2), e199-e201. https://doi.org/10.1212/CPJ.0000000000000884
Yeboah, Kevin, et al. "Interventional Stroke Management in a Patient With COVID-19." Neurology. Clinical practice vol. 11,2 (2021): e199-e201. doi: https://doi.org/10.1212/CPJ.0000000000000884
Yeboah K, Edgell R, Conway J, Alshekhlee A. Interventional Stroke Management in a Patient With COVID-19. Neurol Clin Pract. 2021 Apr;11(2):e199-e201. doi: 10.1212/CPJ.0000000000000884. PMID: 33842093; PMCID: PMC8032437.
Copy Download .nbib Format: NLM
Tumor-Infiltrating B Lymphocyte Profiling Identifies IgG-Biased, Clonally Expanded Prognostic Phenotypes in Triple-Negative Breast Cancer.

Cancer research

Harris RJ, Cheung A, Ng JCF, Laddach R, Chenoweth AM, Crescioli S, Fittall M, Dominguez-Rodriguez D, Roberts J, Levi D, Liu F, Alberts E, Quist J, Santaolalla A, Pinder SE, Gillett C, Hammar N, Irshad S, Van Hemelrijck M, Dunn-Walters DK, Fraternali F, Spicer JF, Lacy KE, Tsoka S, Grigoriadis A, Tutt ANJ, Karagiannis SN.
PMID: 34224371
Cancer Res. 2021 Aug 15;81(16):4290-4304. doi: 10.1158/0008-5472.CAN-20-3773. Epub 2021 Jun 15.

In breast cancer, humoral immune responses may contribute to clinical outcomes, especially in more immunogenic subtypes. Here, we investigated B lymphocyte subsets, immunoglobulin expression, and clonal features in breast tumors, focusing on aggressive triple-negative breast cancers (TNBC). In samples...

Cite
Harris RJ, Cheung A, Ng JCF, et al. Tumor-Infiltrating B Lymphocyte Profiling Identifies IgG-Biased, Clonally Expanded Prognostic Phenotypes in Triple-Negative Breast Cancer. Cancer Res. 2021;81(16):4290-4304doi: 10.1158/0008-5472.CAN-20-3773.
Harris, R. J., Cheung, A., Ng, J. C. F., Laddach, R., Chenoweth, A. M., Crescioli, S., Fittall, M., Dominguez-Rodriguez, D., Roberts, J., Levi, D., Liu, F., Alberts, E., Quist, J., Santaolalla, A., Pinder, S. E., Gillett, C., Hammar, N., Irshad, S., Van Hemelrijck, M., Dunn-Walters, D. K., Fraternali, F., Spicer, J. F., Lacy, K. E., Tsoka, S., Grigoriadis, A., Tutt, A. N. J., & Karagiannis, S. N. (2021). Tumor-Infiltrating B Lymphocyte Profiling Identifies IgG-Biased, Clonally Expanded Prognostic Phenotypes in Triple-Negative Breast Cancer. Cancer research, 81(16), 4290-4304. https://doi.org/10.1158/0008-5472.CAN-20-3773
Harris, Robert J, et al. "Tumor-Infiltrating B Lymphocyte Profiling Identifies IgG-Biased, Clonally Expanded Prognostic Phenotypes in Triple-Negative Breast Cancer." Cancer research vol. 81,16 (2021): 4290-4304. doi: https://doi.org/10.1158/0008-5472.CAN-20-3773
Harris RJ, Cheung A, Ng JCF, Laddach R, Chenoweth AM, Crescioli S, Fittall M, Dominguez-Rodriguez D, Roberts J, Levi D, Liu F, Alberts E, Quist J, Santaolalla A, Pinder SE, Gillett C, Hammar N, Irshad S, Van Hemelrijck M, Dunn-Walters DK, Fraternali F, Spicer JF, Lacy KE, Tsoka S, Grigoriadis A, Tutt ANJ, Karagiannis SN. Tumor-Infiltrating B Lymphocyte Profiling Identifies IgG-Biased, Clonally Expanded Prognostic Phenotypes in Triple-Negative Breast Cancer. Cancer Res. 2021 Aug 15;81(16):4290-4304. doi: 10.1158/0008-5472.CAN-20-3773. Epub 2021 Jun 15. PMID: 34224371; PMCID: PMC7611538.
Copy Download .nbib Format: NLM
Establishing the cost of Xpert MTB/RIF mobile testing in high-burden peri-mining communities in South Africa.

African journal of laboratory medicine

Cassim N, Coetzee LM, Makuraj AL, Stevens WS, Glencross DK.
PMID: 34917494
Afr J Lab Med. 2021 Nov 30;10(1):1229. doi: 10.4102/ajlm.v10i1.1229. eCollection 2021.

BACKGROUND: Globally, tuberculosis remains a major cause of mortality, with an estimated 1.3 million deaths per annum. The Xpert MTB/RIF assay is used as the initial diagnostic test in the tuberculosis diagnostic algorithm. To extend the national tuberculosis testing...

Cite
Cassim N, Coetzee LM, Makuraj AL, et al. Establishing the cost of Xpert MTB/RIF mobile testing in high-burden peri-mining communities in South Africa. Afr J Lab Med. 2021;10(1):1229doi: 10.4102/ajlm.v10i1.1229.
Cassim, N., Coetzee, L. M., Makuraj, A. L., Stevens, W. S., & Glencross, D. K. (2021). Establishing the cost of Xpert MTB/RIF mobile testing in high-burden peri-mining communities in South Africa. African journal of laboratory medicine, 10(1), 1229. https://doi.org/10.4102/ajlm.v10i1.1229
Cassim, Naseem, et al. "Establishing the cost of Xpert MTB/RIF mobile testing in high-burden peri-mining communities in South Africa." African journal of laboratory medicine vol. 10,1 (2021): 1229. doi: https://doi.org/10.4102/ajlm.v10i1.1229
Cassim N, Coetzee LM, Makuraj AL, Stevens WS, Glencross DK. Establishing the cost of Xpert MTB/RIF mobile testing in high-burden peri-mining communities in South Africa. Afr J Lab Med. 2021 Nov 30;10(1):1229. doi: 10.4102/ajlm.v10i1.1229. eCollection 2021. PMID: 34917494; PMCID: PMC8661292.
Copy Download .nbib Format: NLM
Adjustable Sutures in the Treatment of Strabismus: A Report by the American Academy of Ophthalmology.

Ophthalmology

Heidary G, Aakalu VK, Binenbaum G, Chang MY, Morrison DG, VanderVeen DK, Lambert SR, Trivedi RH, Galvin JA, Pineles SL.
PMID: 34446304
Ophthalmology. 2022 Jan;129(1):100-109. doi: 10.1016/j.ophtha.2021.07.026. Epub 2021 Aug 24.

PURPOSE: To review the scientific literature that evaluates the effectiveness of adjustable sutures in the management of strabismus for adult and pediatric patients.METHODS: Literature searches were performed in the PubMed database through April 2021 with no date limitations and...

Cite
Heidary G, Aakalu VK, Binenbaum G, et al. Adjustable Sutures in the Treatment of Strabismus: A Report by the American Academy of Ophthalmology. Ophthalmology. 2021;129(1):100-109doi: 10.1016/j.ophtha.2021.07.026.
Heidary, G., Aakalu, V. K., Binenbaum, G., Chang, M. Y., Morrison, D. G., VanderVeen, D. K., Lambert, S. R., Trivedi, R. H., Galvin, J. A., & Pineles, S. L. (2022). Adjustable Sutures in the Treatment of Strabismus: A Report by the American Academy of Ophthalmology. Ophthalmology, 129(1), 100-109. https://doi.org/10.1016/j.ophtha.2021.07.026
Heidary, Gena, et al. "Adjustable Sutures in the Treatment of Strabismus: A Report by the American Academy of Ophthalmology." Ophthalmology vol. 129,1 (2022): 100-109. doi: https://doi.org/10.1016/j.ophtha.2021.07.026
Heidary G, Aakalu VK, Binenbaum G, Chang MY, Morrison DG, VanderVeen DK, Lambert SR, Trivedi RH, Galvin JA, Pineles SL. Adjustable Sutures in the Treatment of Strabismus: A Report by the American Academy of Ophthalmology. Ophthalmology. 2022 Jan;129(1):100-109. doi: 10.1016/j.ophtha.2021.07.026. Epub 2021 Aug 24. PMID: 34446304.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 332 entries